First EU launch for Levemir in the UK

Article Abstract:

The comparative benefits of Novo Nordisk's Levemir (insulin determir), which has been introduced in United Kingdom (UK) market, for treating diabetes over other similar drugs produced by different companies have been discussed. The approval hurdles faced by Novo Nordisk's Levemir (insulin determir) in the United States and another diabetes drug developed by Novo Nordisk that is undergoing clinical trials has been described.

United Kingdom, Product introduction, New Products/Services, Drug therapy, Diabetes, Diabetes mellitus, Novo Nordisk Ltd., Novo Nordisk Levemir (Medication)

---

How the industry operates

Article Abstract:

The growing demand for drugs despite rising prices and pharmaceutical industry's collaborations with biotechnology firms to develop novel drugs are discussed.

United States, Drugs, Growth, Biotechnology, Company growth

---

Glossary

Article Abstract:

A glossary of terms and reference materials related to pharmaceuticals industry is presented.

Terminology, Glossary

Similar abstracts:

• Abstracts: Market structure and the role of consumer information in the physician services industry: an empirical test. Moral hazard in physician prescription behavior
• Abstracts: Cross-gender mentoring career development in the health care industry. Health care and America's rolling depression
• Abstracts: First launch for Exanta-in Germany. US Senator hits out at FDA for muzzling SSRI reviewer. WHO removes two Cipla HIV drugs from its list
• Abstracts: Children's immunizations: the gap between parents and providers. Effects of community factors on access to ambulatory care for lower-income adults in large urban communities
• Abstracts: How do nonprofit hospitals manage earnings? Performance assessment in the context of multiple objectives: a multivariate multilevel analysis

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.